Page last updated: 2024-09-04

ampelopsin and Neurogenic Inflammation

ampelopsin has been researched along with Neurogenic Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, X; Chen, F; Han, L; Li, X; Weng, L; Xu, Y; Zhan, H; Zhang, H	1

Other Studies

1 other study(ies) available for ampelopsin and Neurogenic Inflammation

Article	Year
Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia. International immunopharmacology, 2017, Volume: 44 Topics: Ampelopsis; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Dinoprostone; Flavonoids; Humans; Inflammation Mediators; Janus Kinase 2; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Neurogenic Inflammation; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Signal Transduction; STAT3 Transcription Factor	2017

Article

Year

Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia.

International immunopharmacology, 2017, Volume: 44

Topics: Ampelopsis; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Dinoprostone; Flavonoids; Humans; Inflammation Mediators; Janus Kinase 2; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Neurogenic Inflammation; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Signal Transduction; STAT3 Transcription Factor

2017